Clinical Trials Logo
  1. Home
  2. Ulcers
  3. NCT01138436

A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers

Ulcers Clinical Trial

Official title:
A Phase II, Randomized, Controlled, Two-Center Pilot Study of the Safety and Efficacy of Topically Applied MEBO® Wound Ointment Compared to Standard of Care in Subjects With Venous Leg Ulcers

Clinical Trial Summary

This is a Phase II, randomized, controlled, two-center pilot study designed to assess the safety and efficacy of MEBO in the treatment of 14 subjects with VLUs. Subjects meeting entry criteria will be randomly assigned in a 1:1 ratio for up to 8 weeks of treatment with either MEBO or SOC (7 subjects per treatment arm).

Clinical Trial Description

To assess the safety and efficacy of MEBO in the treatment of 14 subjects with VLUs. Subjects meeting entry criteria will be randomly assigned in a 1:1 ratio for up to 8 weeks of treatment with either MEBO or SOC (7 subjects per treatment arm). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01138436
Study type Interventional
Source Skingenix, Inc.
Contact
Status Completed
Phase Phase 2
Start date November 2010
Completion date October 2011
View Details
See also
  Status Clinical Trial Phase
Completed NCT01214811 - Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing Phase 3
Terminated NCT00700154 - Insulin Infusion Diabetes Ulcer N/A
Completed NCT01548378 - Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia Phase 2
Completed NCT01942941 - Peripheral Vascular Disease and Nerve Stimulation N/A
Completed NCT00718978 - Clinical Application of Autologous Three-Cellular Cultured Skin Substitutes (CSS) N/A
Completed NCT00951080 - SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds N/A
Suspended NCT00701974 - Non-inferiority Clinic of Kollagenase® Compared Iruxol® in Treatment of Cutaneous Ulcers Phase 2/Phase 3
Completed NCT01474109 - Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients Phase 3
Terminated NCT01474122 - Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients Phase 3
Completed NCT01439581 - Utility of Interface Pressure Mapping N/A
Completed NCT00597818 - Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury Phase 2
Completed NCT00189540 - Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers Phase 2
Recruiting NCT04275323 - Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-1) Phase 3
Completed NCT04274049 - Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-2) Phase 3
Completed NCT00688428 - Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination Phase 1